Doxycycline: Clinical Trials

90 trials of Doxycycline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 completed, 13 unknown, 6 recruiting, 6 terminated. 90 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 490Completed 55, Unknown 13, Recruiting 6, Terminated 6, Not yet recruiting 5, Active not recruiting 2, Withdrawn 2, Enrolling by invitation 1

Follow Doxycycline: new trials by email Literature Review of Doxycycline trials Research Report on Doxycycline

Trials (filtered) newest first · largest first

All 90 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.
Hydroxychloroquin, Placebo, Doxycycline - Lyme Borreliosis, Nervous System
Phase 4Not yet recruitingRadboud University Medical Center502027-03-012026-08-27
A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States
Doxycycline, Standard of Care (SOC) - Chlamydia Females, Gonorrhea Female
Phase 4Not yet recruitingTulane University5192027-01-012026-07-15
These Studies That Evaluated the Efficacy of Antibiotics for Leptospirosis Treatment.
Doxycycline, Placebo - Leptospirosis, Chemoprophylaxis
Phase 4Not yet recruitingChulalongkorn University10002026-11-012026-10-08
Clinical and Radiographic Evaluation of Doxycycline and Atorvastatin Loaded Chitosan Nanoparticles as an Adjunctive to Scaling and Root Planning in the Management of Chronic Periodontitis. A Randomized Controlled Clinical Trial.
Doxycycline and Atorvastatin loaded Chitosan nanoparticles local drug - Chronic Periodontitis
Phase 4Not yet recruitingFayoum University802026-06-012026-06-08
Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
Sarecycline, Doxycycline - Acne Vulgaris
Phase 4RecruitingIntegrative Skin Science and Research302026-04-202026-04-22
Doxycycline vs. Macrolide for MRMP (DOMINO)
Doxycycline, Azithromycin - Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia
Phase 4Not yet recruitingYoung June Choe2082026-03-012025-12-29
Got Doxy- 'Flipping the Script' on STI PEP
Doxycycline monohydrate 200 mg, Observation - Sexually Transmitted Infections (STI)
Phase 4RecruitingEmory University2002025-10-132026-04-30
The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.
Doxycycline (200mg/day) - Syphilis Infection, Gonorrhea
Phase 4RecruitingBangrak STIs Center4002025-10-062026-02-09
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
Doxycycline, Azithromycin - Community-acquired Pneumonia
Phase 4RecruitingMayo Clinic11202025-09-152026-09-24
Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris
oral metformin, Oral doxycycline - Acne Vulgaris on the Face, Acne Vulgaris
Phase 4CompletedGhurki Trust and Teaching Hospital682025-02-152026-01-22
Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens
Doxycycline - Sexually Transmitted Infection
Phase 4CompletedEmory University242024-09-132026-05-01
Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, Kenya
Doxycycline - STI
Phase 4CompletedUniversity of Washington602024-08-132026-04-13
An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures
Clindamycin, Doxycycline - Bacteremia, Endocarditis
Phase 4UnknownUniversity of Santiago de Compostela1502024-07-152024-06-17
A Study of Doxycycline to Treat Chlamydial Infection
Doxycycline, Placebo - Chlamydial Infection
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)5262024-01-192026-11-10
Comparing Oral Versus Parenteral Antimicrobial Therapy
Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem - Endovascular Infection, Bone and Joint Infection
Phase 4TerminatedWest Virginia University942023-08-042025-08-26
Ocular Rosacea Biome Study
Doxycycline 40 MG ( 20mg twice daily), Doxycycline 200 MG ( 100 mg twice daily), Placebo - Ocular Rosacea, Antimicrobial Resistance
Phase 4CompletedUniversity of California, San Francisco462023-06-222026-10-27
Doxycycline for Helicobacter Pylori Rescue Treatment
Esomeprazole, Bismuth Potassium Citrate, Tetracycline - Helicobacter Pylori Infection
Phase 4RecruitingShanghai Jiao Tong University School of Medicine3682023-06-202024-12-30
Doxy-Post-exposure Prophylaxis
Doxycycline - Sexually Transmitted Diseases
Phase 4CompletedEmory University452023-05-312025-09-11
Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline
Doxycycline, Ceftriaxone, benzathine penicillin G - Early Syphilis
Phase 4TerminatedNational Taiwan University Hospital1092023-03-102026-02-25
Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
Spironolactone, Doxycycline Hyclate - Acne
Phase 4Active not recruitingUniversity of Pennsylvania3502022-03-302026-08-25

Showing 20 of 90. Sign in to see all of them.

Conditions studied

Acne Vulgaris (10)  ·  Sexually Transmitted Diseases (10)  ·  Rosacea (8)  ·  Gonorrhea (4)  ·  Infections (4)  ·  Syphilis (4)  ·  COVID-19 (3)  ·  Chlamydia Infections (3)  ·  Pulmonary Disease, Chronic Obstructive (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Borrelia Infections (2)  ·  Community-Acquired Pneumonia (2)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Glossitis, Benign Migratory (2)

Sponsors

Galderma R&D (7)  ·  Emory University (5)  ·  Radboud University Medical Center (3)  ·  British Columbia Centre for Disease Control (2)  ·  Damascus Hospital (2)  ·  Derm Research, PLLC (2)  ·  Mayo Clinic (2)  ·  Medical Center Alkmaar (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Shanghai Zhongshan Hospital (2)  ·  University of Washington (2)  ·  Bangrak STIs Center (1)  ·  Bulovka Hospital (1)  ·  Chulalongkorn University (1)  ·  CollaGenex Pharmaceuticals (1)

Countries

United States (43)  ·  Canada (5)  ·  China (5)  ·  Netherlands (4)  ·  Kenya (3)  ·  Egypt (2)  ·  France (2)  ·  India (2)  ·  Israel (2)  ·  South Korea (2)  ·  Syria (2)  ·  Thailand (2)  ·  Austria (1)  ·  Brazil (1)  ·  Cameroon (1)

Top investigators

Colleen Kelley, MD, MPH (4)  ·  Ronald W Gottschalk, MD (3)  ·  Marouf M Alhalabi, MD (2)  ·  Taotao Liu, MD (2)  ·  Troy Grennan, MD (2)  ·  Adam Zanation, MD (1)  ·  Alina Tone, MD (1)  ·  Alireza Minagar, MD (1)  ·  Amy J McMichael, MD (1)  ·  Angelo Secci, MD (1)  ·  Arie Levine, MD (1)  ·  Arif R. Sarwari, MD, MSc, MBA (1)  ·  Assoc. Prof. Daniel Paris (1)  ·  Avni Thakore, MD (1)

Results publications

PMID 41701614, PMID 38118022, PMID 10738419, PMID 11296335, PMID 11383749, PMID 11438138, PMID 12050508, PMID 15201781, PMID 15232785, PMID 15917525, PMID 15986343, PMID 16979286, PMID 17029130, PMID 17321157, PMID 18052736, PMID 18071030, PMID 18165398, PMID 19875685, PMID 19884021, PMID 20110457, PMID 20489573, PMID 20576731, PMID 20645521, PMID 21070486, PMID 21167743, PMID 21240577, PMID 21398284, PMID 22024822, PMID 22385260, PMID 22668581, PMID 22707212, PMID 22805273, PMID 22981447, PMID 23025537, PMID 23459495, PMID 24059744, PMID 24066290, PMID 24277028, PMID 24421044, PMID 25350566, PMID 25414157, PMID 25572886, PMID 25585069, PMID 25637520, PMID 25801708, PMID 25870333, PMID 26220080, PMID 26283670, PMID 26616678, PMID 26691247

NIH funding

R01AI145971 (2), 2009 (1), 2025 (1), 5UM1AI148684-03 (1), M01RR000827 (1), P20RR017696 (1), P30DK063491 (1), R01AI192319 (1), R01MH123724 (1), R61HL183016 (1), U01AR079752 (1)